By Junex Doronio
CAVITE – Apparently taking into heart the age-old adage that haste makes waste and 110 million lives are at stake, Cavite Governor Jonvic Remulla on Thursday cautioned the Department of Health to make sure the safety and efficacy of the Russian-made vaccine Sputnik V.
At the same time, the governor revealed that two pharmaceutical companies in the province here are now about to undergo Phase 3 of field trial of their experimental vaccine — playfully dubbed by Remulla on his Facebook post as “Etivaccine” — which will involve some 10,000 volunteer recipients.
“Etivaccine” is Cavite vaccine in reverse.
“Ako po ay nababahala sa mainit na balita na ang Russia ay maglalabas na ng vaccine para sa COVID-19. I have nothing against the Russians nor am I connected to any preferred country or vaccine manufacturer. I do not stand to gain on this but forgive me if my primary interest is to safeguard the health and safety of my constituents in Cavite,” Remulla said.
He explained that as far as he knows the Russian data is unavailable, their methodology is not open and its efficacy has not been subject to a review and analysis.
“Dengvaxia is a feasible example of a vaccine gone bad. Many died from its misuse and because of this many became anti to the use of vaccines,” Remulla noted.
With this in mind, Remulla asked the DOH to safeguard the process of review, approval, and appropriation of the COVID-19 vaccine.
“There is no bigger decision than choosing a clinically tested and effective vaccine, at the correct time, at the fair price,” Remulla stressed.
Meanwhile, the governor exudes optimism on Etivaccine.
“Ang Cavite ay malapit na sumailalim sa Phase 3 field trial ng dalawang kilalang pharmaceutical giant. Kasama sa pag-aaral ay ang mahigit sa 10,000 volunteer recipients ng experimental vaccine,” Remulla said.
He added: “Sa trial na gagawin, 5,000 dito ay tatanggap ng bakuna habang 5,000 ay placebo. Ang ibig sabihin po ng placebo, ang matatanggap ng kalahati ay walang therapeutic effect. Ito ay standard protocol sa lahat ng clinical trials na ginagawa sa buong mundo.”
He assured that the trial will undergo intense scrutiny with the scientific community to determine its validity and efficacy.
“Only then will the vaccine be made available to the public,” Remulla said. (MTVN)